Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Coates

Showing results (211-220 of 343) with videos related to

Pageof 35
Sort By:
Joint Bone Spine|March 8, 2022
Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysisFlorian Lucasson, Andra Balanescu, Uta Kiltz, et al.
RMD Open|January 31, 2024
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritisLaure Gossec, Ana-Maria Orbai, Laura C Coates, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 studyLaura C Coates, Peter Nash, Tore K Kvien, et al.
Rheumatology and Therapy|November 11, 2018
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 StudiesPeter Nash, Laura C Coates, Roy Fleischmann, et al.
Rheumatology (Oxford, England)|January 30, 2026
Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: ReplyLekshmi Minikumari Rahulan, Laura C Coates, Laura Andreoli, et al.
RMD Open|March 26, 2024
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled studyLaura C Coates, Laure Gossec, Miriam Zimmermann, et al.
RMD Open|July 21, 2022
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trialPhilip S Helliwell, Phillip J Mease, Arthur Kavanaugh, et al.
Journal of the American Academy of Dermatology|June 22, 2018
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studiesFarzad Alinaghi, Monika Calov, Lars Erik Kristensen, et al.
The Journal of Rheumatology|October 3, 2019
Prevalence of Psoriatic Arthritis Patients Achieving Minimal Disease Activity in Real-world Studies and Randomized Clinical Trials: Systematic Review with MetaanalysisMariele Zardin-Moraes, André Luis Ferreira Azeredo da Silva, Carla Saldanha, et al.
Annals of the Rheumatic Diseases|May 10, 2017
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage studyAlexander Egeberg, Lars Erik Kristensen, Jacob P Thyssen, et al.
Pageof 35

Showing results (211-220 of 343) with videos related to

Sort By:
Pageof 35
Joint Bone Spine|March 8, 2022
Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysisFlorian Lucasson, Andra Balanescu, Uta Kiltz, et al.
RMD Open|January 31, 2024
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritisLaure Gossec, Ana-Maria Orbai, Laura C Coates, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 studyLaura C Coates, Peter Nash, Tore K Kvien, et al.
Rheumatology and Therapy|November 11, 2018
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 StudiesPeter Nash, Laura C Coates, Roy Fleischmann, et al.
Rheumatology (Oxford, England)|January 30, 2026
Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: ReplyLekshmi Minikumari Rahulan, Laura C Coates, Laura Andreoli, et al.
RMD Open|March 26, 2024
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled studyLaura C Coates, Laure Gossec, Miriam Zimmermann, et al.
RMD Open|July 21, 2022
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trialPhilip S Helliwell, Phillip J Mease, Arthur Kavanaugh, et al.
Journal of the American Academy of Dermatology|June 22, 2018
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studiesFarzad Alinaghi, Monika Calov, Lars Erik Kristensen, et al.
The Journal of Rheumatology|October 3, 2019
Prevalence of Psoriatic Arthritis Patients Achieving Minimal Disease Activity in Real-world Studies and Randomized Clinical Trials: Systematic Review with MetaanalysisMariele Zardin-Moraes, André Luis Ferreira Azeredo da Silva, Carla Saldanha, et al.
Annals of the Rheumatic Diseases|May 10, 2017
Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage studyAlexander Egeberg, Lars Erik Kristensen, Jacob P Thyssen, et al.
Pageof 35